Noradrenergic activity and spontaneous recurrence of methamphetamine psychosis

Drug and Alcohol Dependence

Volumn 44, Issue 2-3, 1997, Pages 183-187

  Yui, Kunio ^a,b   Goto, Kimihiko ^c   Ishiguro, Takeo ^b   Ikemoto, Shigenori ^b  

^a Ministry of Justice   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c Yamazaki College   (Japan)

Author keywords

Flashbacks; Methamphetamine psychosis; Norepinephrine; Stressor; Threatening experience

Indexed keywords

METHAMPHETAMINE; MONOAMINE; NORADRENALIN;

ADULT; ARTICLE; CONTROLLED STUDY; FEAR; FEMALE; HALLUCINATION; HUMAN; MAJOR CLINICAL STUDY; NORADRENALIN BLOOD LEVEL; NORADRENERGIC NERVE; PRIORITY JOURNAL; PSYCHOSIS; RECURRENT DISEASE;

ADULT; AROUSAL; FEAR; FEMALE; HUMANS; MENTAL RECALL; METHAMPHETAMINE; NOREPINEPHRINE; PSYCHOSES, SUBSTANCE-INDUCED; SUBSTANCE-RELATED DISORDERS;

EID: 0030934615     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(97)01336-7     Document Type: Article

References (15)

1. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, American Psychiatric Association, Washington, DC.
2. American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders, Third Edition Revised, American Psychiatric Association, Washington, DC.
3. Davies, C.L. and Molyneux, S.G. (1982) Routine determination of plasma catecholamines using reversed-phase, ion-pair high-performance liquid chromatography with electrochemical detention. J. Chromatogr. 231, 41-51.
4. Eichler, A.J. and Antelman, S.M. (1979) Sensitization to amphetamine and stress may involve nucleus accumbens and medial frontal cortex. Brain Res. 176, 412-416.
5. Goldstein, D.S., Eisenhofer, G., Sax, F.L., Keiser, H.R. and Kopin, I.J. (1987) Plasma norepinephrine pharmacokinetics during mental challenge. Psychosom. Med. 49, 591-605.
6. Green, A.I., Alam, M.Y., Boshes, R.A., Waternaux, C., Pappalardo, K.M., Fitzgibbon, M.E., Tsuang, M.T. and Schildkraut, J.J. (1993) Haloperidol response and plasma catecholamines and their metabolites. Schizophr. Res. 10, 33-37.
7. Matefy, R.E., Hayes, C and Hirsch, J. (1978) Psychedelic drug flashbacks: subjective reports and biographic data. Addictive Behav. 3, 165-178.
8. Miyazaki, T., Kojima, T., Yashiki, M., Wakamoto, H., Iwasaki, Y. and Taniguchi, T. (1993) Site dependence of methamphetamine concentrations in blood samples collected from cadavers of people who had been methamphetamine abusers. Am. J. Forensic Med. Pathol. 14, 121-124.
9. Nisenbaum, L.K., Zigmond, M.J., Sved, A.F. and Abercrombie, E.D. (1991) Prior exposure to chronic stress results in enhanced synthesis and release of hippocampal norepinephrine in response to a novel stressor. J. Neurosci. 11, 1478-1484.
10. Overall, J.E. and Gorham, D.R. (1962) The Brief Psychiatric Rating Scale. Psychol. Res. 10, 799-812.
11. Risbo, A., Jessen, K. and Hagelsten, J.O. (1983) Catecholamine response to the clinical use of alpha adrenergic receptor blocking agents. Acta Anaesthesiol. Scand. 27, 72-74.
12. Spielberger, C.D. (1983) Manual for the State-Trait Anxiety Inventory. Consulting Psychologists Press, Palo Alto, CA.
13. Tuck, J.R. (1973) Effects of chlorpromazine, thioridazine and haloperidol on adrenergic transmitter mechanisms in man. Eur. J. Clin. Pharmacol. 6, 81-87.
14. Ward, M.M., Mefford, I.N., Parker, S.D., Chesney, M.A., Taylor, C.B., Keegan, D.L. and Barchas, J.D. (1983) Epinephrine and norepinephrine responses in continuously collected human plasma to a series of stressors. Psychosom. Med. 45, 471-486.
15. Ziegler, M.G., Lake, C.R., Wood, J.H., Brooks, B.R. and Ebert, M.H. (1977) Relationship between norepinephrine in blood and cerebrospinal fluid in the presence of a blood-cerebrospinal fluid barrier for norepinephrine. J. Neurochem. 28, 677-679.